Daré Bioscience Announces FDA Clearance of IND for Phase 2 Clinical Study of DARE-HPV, a Potential Treatment for Persistent High-Risk HPV Infection, the Most Common Cause of ...

Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real-world solutions, today announced ...
CURE

FDA Clears Trial Application for FG001 in Brain Cancer

The U.S. Food and Drug Administration (FDA) has cleared an investigational new drug application from FluoGuide A/S in Copenhagen, Denmark, allowing the company to move forward in the U.S. with a ...

MEDIPOST files IND amendment to FDA for Phase III osteoarthritis trial

MEDIPOST has submitted an investigational new drug (IND) amendment to the US Food and Drug Administration (FDA) to initiate a ...
GlobalData on MSN

FDA approves PharmaResearch IND application for PRD-101 trial

The trial will be conducted at up to seven US sites, enrolling 90 patients with advanced or metastatic solid tumours.

Life Biosciences Announces FDA Clearance of IND Application for ER-100 in Optic Neuropathies

BOSTON, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Life Biosciences, Inc., (“Life Bio”) a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging, ...